← Back to all trials
Not Yet Recruiting
NCT07852611
Auricular Point Acupressure for Pain
Conditions: HIV (Human Immunodeficiency Virus), Pain
Sex: All
Ages: 50 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 30
Sponsor: Dan Song
Location: Texas A&M University-Corpus Christi Corpus Christi Texas
Summary
The goal of this pilot clinical trial is to learn whether auricular point acupressure (APA) can help reduce chronic musculoskeletal pain in adults age 50 and older who are living with HIV. The study will also examine whether APA is feasible, acceptable, and safe for this population. The main questions it aims to answer are:
Does APA reduce chronic musculoskeletal pain and improve sleep and quality of life? Is APA feasible, acceptable, and safe for older people living with HIV?
Researchers will compare true APA, in which small seeds are taped to specific ear points related to pain, with sham APA, in which seeds are taped to ear points not related to pain. The intervention will last 4 weeks.
Participants will:
Receive true APA or sham APA for 4 weeks Visit the study site weekly for placement of the ear seeds Press the ear seeds for 3 minutes, 3 times each day Complete daily surveys about pain and pain medication use Use a sleep monitor to track sleep Complete study assessments at the beginning and end of the intervention Complete an exit interview about their experience with APA
Eligibility Criteria
Inclusion Criteria:
* Age 50 years or older
* Living with HIV
* Chronic musculoskeletal pain affecting the muscles, joints, or bones for at least 3 months
* Average chronic musculoskeletal pain intensity of ≥4 on a 0-10 Numeric Pain Rating Scale during the past week
Exclusion Criteria:
* Recent trauma as the primary cause of pain
* Concurrent use of other adjunctive pain therapies, including physical therapy, chiropractic treatment, or acupuncture
* Allergy to latex due to the use of latex-containing tape on the ear points Presence of acute pain
Source: ClinicalTrials.gov (NCT07852611). StuddyBuddy aggregates publicly available trial information.